This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, R. N.
Right arrow Articles by Walter, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, R. N.
Right arrow Articles by Walter, D. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2002, p. 461-465, Vol. 40, No. 2
0095-1137/01/$04.00+0     DOI: 10.1128/JCM.40.2.461-465.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Tiamulin Activity against Fastidious and Nonfastidious Veterinary and Human Bacterial Isolates: Initial Development of In Vitro Susceptibility Test Methods

Ronald N. Jones,1,2* Michael A. Pfaller,3 Paul R. Rhomberg,1 and Donald H. Walter4

The JONES Group/JMI Laboratories, North Liberty,1 CAST Laboratories of the University of Iowa College of Medicine, Iowa City, Iowa,3 The Tufts University School of Medicine, Boston, Massachusetts ,2 Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri4

Received 11 September 2001/ Returned for modification 28 October 2001/ Accepted 27 November 2001

Tiamulin is a pleuromutilin derivative used in veterinary practice for the control and specific therapy of infections in swine. This report summarizes studies to establish standardized susceptibility testing methods, interpretive criteria, and reagent details for use in veterinary methods recently developed by the National Committee for Clinical Laboratory Standards (NCCLS) (standards M31-A and M37-A, NCCLS, Wayne, Pa., 1999). A total of 636 fastidious and nonfastidious animal and human pathogens were processed by using media and procedures described by the NCCLS. Tiamulin disk diffusion tests used a 30-µg disk concentration, and the proposed MIC breakpoints corresponding to levels achievable in animal target tissues (lung) were <=4 µg/ml for susceptibility and >=32 µg/ml for resistance. Correlate zone diameters for specific nonfastidious species were as follows: for Pasteurella multocida and staphylococci tested on Mueller-Hinton agar, susceptibility at >=19 mm and resistance at <=11 mm, and for Actinobacillus suis, Erysipelothrix rhusiopathiae, and Streptococcus suis tested on enriched chocolate Mueller-Hinton agar, susceptibility at >=16 mm and resistance at <=8 mm. When Actinobacillus pleuropneumoniae was tested, a susceptibility breakpoint of <=16 µg/ml (>=9 mm) was suggested for veterinary fastidious medium broth and enriched chocolate Mueller-Hinton agar. Absolute categorical agreement between NCCLS dilution and disk diffusion test results with these criteria ranged from 90.5 to 96.2%. Tiamulin susceptibility testing methods appear to be accurate in their categorical classification for indicated species, and their availability will allow immediate testing of animal isolates to guide therapy via appropriate levels of dosing and to monitor the development of resistance for agents in this unique class.

* Corresponding author. Mailing address: 345 Beaver Kreek Centre, Suite A, North Liberty, IA 52317. Phone: (319) 665-3370. Fax: (319) 665-3371. E-mail: ronald-jones{at}jmilabs.com.

Journal of Clinical Microbiology, February 2002, p. 461-465, Vol. 40, No. 2
0095-1137/01/$04.00+0     DOI: 10.1128/JCM.40.2.461-465.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Jones, R. N., Fritsche, T. R., Sader, H. S., Ross, J. E. (2006). Activity of Retapamulin (SB-275833), a Novel Pleuromutilin, against Selected Resistant Gram-Positive Cocci.. Antimicrob. Agents Chemother. 50: 2583-2586 [Abstract] [Full Text]  
  • Ross, J. E., Jones, R. N. (2005). Quality Control Guidelines for Susceptibility Testing of Retapamulin (SB-275833) by Reference and Standardized Methods. J. Clin. Microbiol. 43: 6212-6213 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»